BACKGROUND: The number of patients starting renal replacement therapy (RRT) is increasing in England, as it is worldwide. Improvements in the management of chronic kidney disease (CKD) across communities to alter this trend are a public health priority. We have prospectively studied changes in the incidence and modality of treatment for end-stage renal disease following the introduction of a CKD management programme in the West Midlands region of England. METHODS: Nephrology service to approximately 700 000 adult population of mixed ethnicity in urban and suburban areas, many with social deprivation. The programme was introduced in stages between 2003 and 2006 and comprised primary care education and financial incentives, personal clinical reports written directly to patients following every consultation, routine laboratory estimated glomerular filtration rate (eGFR) reporting, eGFR graph surveillance to identify and monitor patients at risk, multidisciplinary pre-RRT care and conservative care. Prevalent patients: 10 552 with CKD and 8509 without CKD with diabetes. OUTCOMES: access to nephrology care, trends in RRT incidence and starting modality, place of death without RRT. Incident count was adjusted for changes in the local adult population recorded in national censuses. RESULTS: Ninety-one per cent of patients aged ≥75 years with incident CKD stage 5 were known to a nephrologist. The population-adjusted incident RRT rate peaked in 2005 and then declined; the proportion starting with transplant, peritoneal dialysis or haemodialysis by arterio-venous fistula increased to 63% by 2012 (P = 0.001 versus 2005). Fifty-two per cent of patients receiving planned conservative care without dialysis died out of hospital. CONCLUSIONS: Following the introduction of a community-wide systematic CKD management programme, the population-adjusted incidence of RRT reduced, modality of initiation of RRT improved and a majority of patients receiving planned conservative care without dialysis died out of hospital.
BACKGROUND: The number of patients starting renal replacement therapy (RRT) is increasing in England, as it is worldwide. Improvements in the management of chronic kidney disease (CKD) across communities to alter this trend are a public health priority. We have prospectively studied changes in the incidence and modality of treatment for end-stage renal disease following the introduction of a CKD management programme in the West Midlands region of England. METHODS: Nephrology service to approximately 700 000 adult population of mixed ethnicity in urban and suburban areas, many with social deprivation. The programme was introduced in stages between 2003 and 2006 and comprised primary care education and financial incentives, personal clinical reports written directly to patients following every consultation, routine laboratory estimated glomerular filtration rate (eGFR) reporting, eGFR graph surveillance to identify and monitor patients at risk, multidisciplinary pre-RRT care and conservative care. Prevalent patients: 10 552 with CKD and 8509 without CKD with diabetes. OUTCOMES: access to nephrology care, trends in RRT incidence and starting modality, place of death without RRT. Incident count was adjusted for changes in the local adult population recorded in national censuses. RESULTS: Ninety-one per cent of patients aged ≥75 years with incident CKD stage 5 were known to a nephrologist. The population-adjusted incident RRT rate peaked in 2005 and then declined; the proportion starting with transplant, peritoneal dialysis or haemodialysis by arterio-venous fistula increased to 63% by 2012 (P = 0.001 versus 2005). Fifty-two per cent of patients receiving planned conservative care without dialysis died out of hospital. CONCLUSIONS: Following the introduction of a community-wide systematic CKD management programme, the population-adjusted incidence of RRT reduced, modality of initiation of RRT improved and a majority of patients receiving planned conservative care without dialysis died out of hospital.
Entities:
Keywords:
renal replacement therapy; service improvement
Authors: Olivier J Wouters; Donal J O'Donoghue; James Ritchie; Panos G Kanavos; Andrew S Narva Journal: Nat Rev Nephrol Date: 2015-06-09 Impact factor: 28.314
Authors: Michal J Lewandowski; Simon Krenn; Amelie Kurnikowski; Philipp Bretschneider; Martina Sattler; Elisabeth Schwaiger; Marlies Antlanger; Philipp Gauckler; Markus Pirklbauer; Maria Brunner; Sabine Horn; Emanuel Zitt; Bernhard Kirsch; Martin Windpessl; Manfred Wallner; Ida Aringer; Martin Wiesholzer; Manfred Hecking; Sebastian Hödlmoser Journal: Wien Klin Wochenschr Date: 2022-08-31 Impact factor: 2.275
Authors: Patrick Harnett; Matthew Jones; Michael Almond; Gowrie Ballasubramaniam; Vinni Kunnath Journal: Clin Med (Lond) Date: 2018-10 Impact factor: 2.659
Authors: Björn Tampe; Desiree Tampe; Elisabeth M Zeisberg; Gerhard A Müller; Wibke Bechtel-Walz; Michael Koziolek; Raghu Kalluri; Michael Zeisberg Journal: EBioMedicine Date: 2015-01 Impact factor: 8.143
Authors: Hugh Gallagher; Shona Methven; Anna Casula; Nicola Thomas; Charles R V Tomson; Fergus J Caskey; Tracey Rose; Stephen J Walters; David Kennedy; Anne Dawnay; Martin Cassidy; Richard Fluck; Hugh C Rayner; Michael Nation Journal: BMC Nephrol Date: 2017-04-11 Impact factor: 2.388